Description

Haloperidol Octanoate is a long-acting ester prodrug of the typical antipsychotic haloperidol, designed for sustained therapeutic action. This compound is critically important for the development of depot injection formulations, which provide controlled release and improve patient compliance in long-term psychiatric treatment regimens. It is primarily needed by pharmaceutical manufacturers and research institutions focused on neuropsychiatric therapeutics, specifically for the production of long-acting injectable (LAI) antipsychotic medications.

Application

• Long-Acting Injectable (LAI) Antipsychotic Formulations: Primary active pharmaceutical ingredient (API) for depot injections used in the management of schizophrenia and other psychotic disorders.
• Pharmaceutical Intermediate: Key synthetic precursor in the production of haloperidol-based controlled-release medications.
• Neuropsychiatric Research: Used in preclinical and clinical studies to investigate the pharmacokinetics and efficacy of esterified antipsychotic drugs.
• Drug Delivery System Development: A model compound for researching and optimizing sustained-release parenteral drug delivery platforms.
• Generic Pharmaceutical Manufacturing: Sourcing for companies producing generic versions of long-acting haloperidol decanoate therapies, where the octanoate ester offers a related profile.

Basic Information

Product Name	Haloperidol Octanoate
CAS No.	1134807-34-3
Molecular Formula	C31H41ClFNO3
Molecular Weight	530.12 g/mol
Synonyms	Haloperidol Octanoate; 4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone Octanoate; Haloperidol Caprylate; Haloperidol Octanoic Acid Ester; 1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-, octanoate; Haloperidol Monoocatanoate
EINECS	Contact for details

Quality Control

Our Haloperidol Octanoate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting high standards for pharmaceutical intermediates. A comprehensive Certificate of Analysis (COA) detailing purity, related substances, residual solvents, and other critical parameters is provided with every shipment to support your quality and regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to protect the product from moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.